HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mayumi Sato Selected Research
Mayumi Sato Research Topics
Disease
6
Neoplasms (Cancer)
11/2010 - 11/2004
3
Type 2 Diabetes Mellitus (MODY)
07/2011 - 01/2002
2
Epilepsy (Aura)
03/2015 - 02/2012
2
Migraine with Aura (Familial Hemiplegic Migraine)
03/2015 - 02/2012
2
Atherosclerosis
07/2011 - 10/2003
2
Neoplasm Metastasis (Metastasis)
11/2010 - 08/2008
2
MELAS Syndrome (Syndrome, MELAS)
03/2009 - 06/2007
2
Vomiting
05/2006 - 01/2006
2
Lung Neoplasms (Lung Cancer)
05/2006 - 01/2006
1
Rheumatoid Arthritis
01/2024
1
Schizophrenia (Dementia Praecox)
12/2021
1
Body Weight (Weight, Body)
01/2021
1
Deglutition Disorders (Dysphagia)
01/2021
1
Hyperlipidemias (Hyperlipidemia)
01/2014
1
Hypercholesterolemia
01/2014
1
Coronary Disease (Coronary Heart Disease)
01/2014
1
Arteriosclerosis
01/2013
1
Hemiplegia (Spastic Hemiplegia)
02/2012
1
Cardiovascular Diseases (Cardiovascular Disease)
07/2011
1
Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2011
1
Ischemic Stroke
03/2009
1
Carotid Stenosis (Carotid Artery Stenosis)
03/2009
1
Colorectal Neoplasms (Colorectal Cancer)
04/2008
1
Starvation
01/2008
1
Pancreatic Neoplasms (Pancreatic Cancer)
09/2007
1
Carcinoma (Carcinomatosis)
02/2007
1
Hepatocellular Carcinoma (Hepatoma)
08/2006
1
Nausea
05/2006
1
Mental Disorders (Mental Disorder)
10/2005
1
Fibrosarcoma
05/2005
1
Hypoxia (Hypoxemia)
04/2005
1
Coma (Comas)
01/2004
1
Emaciation
01/2004
1
Hypophosphatemia
01/2004
1
Hypothermia
01/2004
1
Bradycardia
01/2004
1
Hypotension (Low Blood Pressure)
01/2004
1
Hepatitis
01/2004
1
Insulin Resistance
04/2002
1
Hyperglycemia
01/2002
Drug/Important Bio-Agent (IBA)
3
Proteins (Proteins, Gene)
FDA Link
12/2021 - 04/2008
3
Glucose (Dextrose)
FDA Link
Generic
03/2015 - 01/2002
3
Insulin (Novolin)
FDA Link
07/2011 - 01/2002
2
Hempa (Hexamethylphosphoramide)
IBA
03/2015 - 02/2012
2
Ifosfamide
FDA Link
Generic
05/2006 - 01/2006
2
Irinotecan (Camptosar)
FDA Link
Generic
05/2006 - 01/2006
2
Cisplatin (Platino)
FDA Link
Generic
05/2006 - 01/2006
2
Hypoglycemic Agents (Hypoglycemics)
IBA
01/2004 - 01/2002
1
Methotrexate (Mexate)
FDA Link
Generic
01/2024
1
Fatty Acid-Binding Protein 7
IBA
12/2021
1
Environmental Biomarkers
IBA
12/2021
1
Biomarkers (Surrogate Marker)
IBA
12/2021
1
Serum Albumin
IBA
01/2021
1
Zinc
IBA
01/2021
1
Cholesterol
IBA
01/2014
1
Niacin (Nicotinic Acid)
FDA Link
Generic
01/2014
1
Adipokines
IBA
01/2013
1
Serum Amyloid A Protein (Serum Amyloid A)
IBA
01/2013
1
Fatty Acids (Saturated Fatty Acids)
IBA
01/2013
1
norlichexanthone
IBA
07/2011
1
Adiponectin
IBA
07/2011
1
nobiletin
IBA
11/2010
1
Mitochondrial DNA (mtDNA)
IBA
03/2009
1
Phenylalanine (L-Phenylalanine)
FDA Link
03/2009
1
Transfer RNA (tRNA)
IBA
03/2009
1
Heparitin Sulfate (Heparan Sulfate)
IBA
08/2008
1
Enzymes
IBA
08/2008
1
heparanase
IBA
08/2008
1
Platinum
IBA
04/2008
1
Decorin
IBA
01/2008
1
Vorinostat
FDA Link
09/2007
1
Histone Deacetylase Inhibitors
IBA
09/2007
1
Acetazolamide (Diamox)
FDA Link
Generic
06/2007
1
monorden (radicicol)
IBA
02/2007
1
anthracene
IBA
02/2007
1
Angiogenesis Inhibitors
IBA
02/2007
1
Hydroxyl Radical
IBA
02/2007
1
DNA (Deoxyribonucleic Acid)
IBA
08/2006
1
Complementary DNA (cDNA)
IBA
08/2006
1
Monoclonal Antibodies
IBA
08/2006
1
ramosetron (Nasea)
IBA
05/2006
1
azasetron
IBA
05/2006
1
Dexamethasone (Maxidex)
FDA Link
Generic
01/2006
1
Cathartics (Purgatives)
IBA
10/2005
1
CXC Chemokines
IBA
05/2005
1
Fas Ligand Protein (Fas Ligand)
IBA
05/2005
1
Chemokines
IBA
05/2005
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
04/2005
1
synerazol
IBA
11/2004
1
Thromboxanes
IBA
10/2003
1
voglibose (Basen)
IBA
04/2002
1
Glyburide (Glibenclamide)
FDA Link
Generic
04/2002
1
Terpenes (Terpenoids)
IBA
01/2002
1
Thiazolidines
IBA
01/2002
1
dehydrotrametenolic acid
IBA
01/2002
1
ciglitazone
IBA
01/2002
Therapy/Procedure
3
Drug Therapy (Chemotherapy)
04/2008 - 01/2006
2
Therapeutics
05/2006 - 01/2006
1
Renal Dialysis (Hemodialysis)
04/2008
1
Aftercare (After-Treatment)
04/2002